Back to Search Start Over

Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists

Authors :
Bugatti A
Giagulli C
Urbinati C
Caccuri F
Chiodelli P
Oreste P
Fiorentini S
Orro A
Milanesi L
D'Ursi P
Caruso A
Rusnati M.
Source :
The Journal of biological chemistry, 288 (2013): 1150–1161. doi:10.1074/jbc.M112.400077, info:cnr-pdr/source/autori:Bugatti A, Giagulli C, Urbinati C, Caccuri F, Chiodelli P, Oreste P, Fiorentini S, Orro A, Milanesi L, D'Ursi P, Caruso A, Rusnati M./titolo:Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists./doi:10.1074%2Fjbc.M112.400077/rivista:The Journal of biological chemistry (Print)/anno:2013/pagina_da:1150/pagina_a:1161/intervallo_pagine:1150–1161/volume:288
Publication Year :
2013
Publisher :
American Society for Biochemistry and Molecular Biology [etc.], [Baltimore, etc.], Stati Uniti d'America, 2013.

Abstract

Background: HIV-1 p17 binds heparin and heparan sulfate proteoglycans of the cell surface. Results: Heparin/p17interactionoccursthroughheparinsulfategroupsandalinearbasicmotifofp17Nterminus,alsoinvolved in p17/CXCR1 interaction. Conclusion: Targeting the basic motif inhibits p17-receptors interaction and consequent biological activities. Significance: Heparin-like molecules represent template for the development of new treatments of p17-dependent/AIDS- associated pathologies.

Details

Language :
English
Database :
OpenAIRE
Journal :
The Journal of biological chemistry, 288 (2013): 1150–1161. doi:10.1074/jbc.M112.400077, info:cnr-pdr/source/autori:Bugatti A, Giagulli C, Urbinati C, Caccuri F, Chiodelli P, Oreste P, Fiorentini S, Orro A, Milanesi L, D'Ursi P, Caruso A, Rusnati M./titolo:Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists./doi:10.1074%2Fjbc.M112.400077/rivista:The Journal of biological chemistry (Print)/anno:2013/pagina_da:1150/pagina_a:1161/intervallo_pagine:1150–1161/volume:288
Accession number :
edsair.cnr...........38891c2402e0e9e91508845b5bff9120
Full Text :
https://doi.org/10.1074/jbc.M112.400077